Torbjörn Skrold
CEO
Replay available
Bonesupport Holding AB (publ) (STO: BONEX) Q3 2025 earnings conference call, held 2025-10-23. Replay captured from the company's public earnings webcast.

CEO
CFO
Analyst, Danske Bank
Analyst, Nordea
Analyst, SEB
Analyst, Carnegie
Analyst, ABG Sundal Collier
Analyst, Stifel
Watch the replay and follow the connected company analysis, news, and investor updates for Bonesupport Holding Ab.
WEBVTT 00:00:00.470 -- 00:00:04.817 Welcome everyone to Bonesupport's Q3 2025 results call. 00:00:04.817 -- 00:00:09.364 My name is Torbjörn Skrold and since September 1st, I'm the CEO of Bonesupport. 00:00:09.364 -- 00:00:14.372 With me here today is our CFO, Håkan Johansson, and together the two of us will use 00:00:14.372 -- 00:00:19.500 the next 25 minutes to guide you through the Q2 report and then open the line for 00:00:19.500 -- 00:00:21.563 any questions. 00:00:21.563 -- 00:00:26.608 Before starting the presentation, I would like to draw your attention to the 00:00:26.608 -- 00:00:32.154 disclaimers covering any forward-looking statements that we will make today. 00:00:32.154 -- 00:00:37.279 Next slide, please. So let's look at the financial and operational highlights 00:00:37.279 -- 00:00:43.025 from the quarter. Q3 was another strong quarter with solid execution across the business. 00:00:43.025 -- 00:00:49.650 Net sales came in at 294 million, corresponding to a growth of 24% versus Q3 2024. 00:00:50.875 -- 00:00:56.221 Sales growth at constant exchange rate was 34%, showing that there's continued strong 00:00:56.221 -- 00:01:00.345 currency impact on our figures for the quarter. 00:01:00.345 -- 00:01:06.472 Our operating results excluding incentive program effects was 79 million, corresponding 00:01:06.472 -- 00:01:10.837 to an adjusted operating margin of 27%. Reported 00:01:10.837 -- 00:01:15.842 operating results was 65 million, and we saw strong cash generation 00:01:15.842 -- 00:01:18.483 with operating cash 00:01:22.752 -- 00:01:24.394 379 00:01:24.394 -- 00:01:26.357 million. 00:01:26.357 -- 00:01:31.465 One highlight in the quarter was the publication of the long-awaited Serahip study, 00:01:31.465 -- 00:01:36.913 which now kicks off our market p...